Inflammatory Cytokines, Apoptotic, Tissue Injury and Remodeling Biomarkers in Children with Congenital Heart Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Indian Journal of Clinical Biochemistry

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12291-013-0341-0PMID 24757294PMCID PMC3990814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers in pediatric heart failure: Their role in diagnosis and evaluating disease progression

  2011influential reference
• [The Rotterdam study].

  2011cited by this paper
• The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.

  2010cited by this paper
• A sensitive cardiac troponin T assay in stable coronary artery disease.

  2009influential reference
• Associations between neurohormonal and inflammatory activation and heart failure in children.

  2008cited by this paper
• Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro.

  2007cited by this paper
• C-reactive protein and risk of heart failure. The Rotterdam Study.

  2006cited by this paper
• Cyanotic congenital heart disease and coronary artery atherogenesis.

  2005cited by this paper
• Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.

  2003influential reference
• Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.

  2003cited by this paper
• Coagulation abnormalities in patients with cyanotic congenital heart disease.

  2002cited by this paper
• Cardiac function, microvascular structure, and capillary hematocrit in hearts of polycythemic rats.

  2001cited by this paper
• Role of Endothelial Nitric Oxide in Shear Stress—Induced Vasodilation of Human Microvasculature: Diminished Activity in Hypertensive and Hypercholesterolemic Patients

  2001cited by this paper
• Congenital heart disease in adults: First of two parts

  2000cited by this paper
• Plasma Nitric Oxide Products Correlate with Cardiac Index of Congenital Heart Disease

  2000cited by this paper
• Preoperative and postoperative endotoxemia in children with congenital heart disease.

  2000cited by this paper
• Endothelium-derived nitric oxide and vascular physiology and pathology

  1999cited by this paper
• Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

  1999influential reference
• Apoptosis. Basic concepts and implications in coronary artery disease.

  1999cited by this paper
• Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases.

  1999cited by this paper
• Tumor Necrosis Factor-a and Cardiomyopathy

  1998cited by this paper
• Tumor necrosis factor-alpha and cardiomyopathy.

  1998cited by this paper
• Systemic inflammation in patients with heart failure.

  1998cited by this paper
• Cyanotic congenital heart disease : a multisystem disorder

  1998cited by this paper
• Thrombomodulin: An overview and potential implications in vascular disorders

  1998cited by this paper
• The thrombomodulin/protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium.

  1997cited by this paper
• Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.

  1993cited by this paper

• Maternal cytokine and cellular adhesion molecules profile in pregnant women with and without congenital heart disease.

  2025cites this paper
• Imbalance of Fetal Growth Factor Levels in Congenital Heart Disease Pathology: A Systematic Review

  2025cites this paper
• Adults With Congenital Heart Disease Have an Increased Prevalence of Autoimmunity

  2025cites this paper
• Growth Failure in Children with Congenital Heart Disease

  2025cites this paper
• Impact of congenital heart disease on clinical outcomes of oral propranolol therapy for Infantile hemangiomas: a propensity score-matched analysis

  2025cites this paper
• Screening and evaluation of TBX20 and CITED2 mutations in children with congenital cardiac septal defects: Correlation with cardiac troponin T and caspase-3.

  2023cites this paper
• Role of Vascular Endothelial Growth Factor as a Potential Biomarker in Congenital Heart Defects: A Systematic Review

  2023cites this paper
• Comparison of CIMT and FMD in the Brachial Artery between Children with Acyanotic Congenital Heart Disease and Healthy Controls: A Case-Control Study

  2023cites this paper
• Biological Age in Congenital Heart Disease—Exploring the Ticking Clock

  2023cites this paper
• The Anti-Inflammatory and Antioxidant Effects of Propofol and Sevoflurane in Children With Cyanotic Congenital Heart Disease.

  2022cites this paper
• Effects of extended pharmacological disruption of zebrafish embryonic heart biomechanical environment on cardiac function, morphology, and gene expression

  2021cites this paper
• Evaluation of Red Cell Distribution Width and Platelet Indices in Children with Chronic Heart Disease

  2021cites this paper
• Clinical Translation of Discoveries in Cardiomyocyte Biology

  2021cites this paper
• Immunity and inflammation: the neglected key players in congenital heart disease?

  2021cites this paper
• Evaluation of Cardiac Troponin I as a Non Invasive Tool for Diagnosis of the Newborns and Infants Below 6 Months with Congenital Heart Diseases

  2020cites this paper
• Study of serum leptin level in children with cyanotic and acyanotic congenital heart disease

  2020cites this paper
• Effect of ketamine on pro- and anti-inflammatory cytokine response in paediatric cardiac surgery: A prospective randomised controlled study

  2017cites this paper
• Elevated serum levels of ghrelin and TNF-α in patients with cyanotic and acyanotic congenital heart disease

  2017influential citation
• Comparative transcriptomic analysis of porcine peripheral blood reveals differentially expressed genes from the cytokine-cytokine receptor interaction pathway related to health status.

  2017cites this paper
• Emerging Biomarkers of Congenital Heart Diseases and Disorders

  2016cites this paper
• The dynamic change of serum cTnT and NT-ProBNP during the intervention therapy for congenital heart disease and the value for prognosis prediction

  2016cites this paper
• Significant Modules and Biological Processes between Active Components of Salvia miltiorrhiza Depside Salt and Aspirin

  2016cites this paper
• Serum C-reactive protein levels and body mass index in children and adolescents with CHD

  2016cites this paper
• Elevated serum ghrelin, tumor necrosis factor‐α and interleukin‐6 in congenital heart disease

  2016cites this paper
• Myocardial Injury in Children with Unoperated Congenital Heart Diseases

  2015cites this paper